Page 864«..1020..863864865866..870880..»

Target ALS and AFTD Announce $5MM in Grants for Research Targeting Treatments and Biomarkers – Salamanca Press

Posted: Published on May 6th, 2020

NEW YORK, May 5, 2020 /PRNewswire/ --Today, Target ALS and The Association for Frontotemporal Degeneration (AFTD) announced $5 million in funding awards for work by six research teams to aid in the discovery of biomarkers and viable treatments for ALS and frontotemporal degeneration (FTD). ALS and FTD (the most common dementia under 60) overlap in genetic causes and biological mechanisms. By joining forces, Target ALS and AFTD are leveraging the combined expertise of researchers in two fields, fueling collaboration in support of the most promising ideas Continue reading →

Posted in ALS Treatment | Comments Off on Target ALS and AFTD Announce $5MM in Grants for Research Targeting Treatments and Biomarkers – Salamanca Press

Mitsubishi Tanabe Pharma America Marks Third Anniversary Of FDA Approval And Reports More Than 5,000 Patients With ALS Treated With RADICAVA…

Posted: Published on May 6th, 2020

JERSEY CITY, N.J., May 5, 2020 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today reported that more than 5,000 people with amyotrophic lateral sclerosis (ALS) have received the treatment with RADICAVA (edaravone) in North America since the therapy was approved by the U.S. Food and Drug Administration (FDA) on May 5, 2017. Continue reading →

Posted in ALS Treatment | Comments Off on Mitsubishi Tanabe Pharma America Marks Third Anniversary Of FDA Approval And Reports More Than 5,000 Patients With ALS Treated With RADICAVA…

Mitsubishi Tanabe Pharma Canada Announces That Company’s Treatment for Amyotrophic Lateral Sclerosis (ALS) Has Been Added to the Provincial Drug Plan…

Posted: Published on May 6th, 2020

TORONTO, April 29, 2020 /CNW/ -Mitsubishi Tanabe Pharma CorporationCanada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), today announced that RADICAVA (edaravone) is now listed on the Rgie de l'assurance maladie du Qubec (RAMQ) formulary (special authorization). Continue reading →

Posted in ALS Treatment | Comments Off on Mitsubishi Tanabe Pharma Canada Announces That Company’s Treatment for Amyotrophic Lateral Sclerosis (ALS) Has Been Added to the Provincial Drug Plan…

A Jupiter chemist just landed a $11M grant for brain disease research… he’s looking into COVID-19 drugs, too – Palm Beach Post

Posted: Published on May 6th, 2020

Dr. Disneys research confronts diseases that include Alzheimers, ALS, muscular dystrophy and, recently, the coronavirus. JUPITER A scientist at Scripps Research Institute studying brain diseases and the novel coronavirus has received a hefty grant from the National Institute of Neurological Disorders and Stroke. Continue reading →

Posted in ALS Treatment | Comments Off on A Jupiter chemist just landed a $11M grant for brain disease research… he’s looking into COVID-19 drugs, too – Palm Beach Post

A Nebraska man was diagnosed with ALS in January. His family shares how they have had to cope with the terminal disease at home. – Business Insider…

Posted: Published on May 6th, 2020

A year ago, Chad McBride was the chair of the communications studies department at Creighton University in Omaha, Nebraska. He and his husband, Allen Saunders, were raising their 3-year-old son, Jackson, in a close-knit community of friends, neighbours, and colleagues. [Life] was beyond magical, McBride, 44, told Insider. Continue reading →

Posted in ALS Treatment | Comments Off on A Nebraska man was diagnosed with ALS in January. His family shares how they have had to cope with the terminal disease at home. – Business Insider…

Fiagon partners with Smith+Nephew to distribute its ENT surgical navigation portfolio in the Asia Pacific region – BioSpace

Posted: Published on May 6th, 2020

BERLIN, May 5, 2020 /PRNewswire/ --Fiagon, a technology leader who develops and manufactures innovative surgical image guidance technologies, announced today a partnership with Smith+Nephew (NYSE: SNN, LSE: SN), a global medical technology business, to distribute its ENT surgical navigation portfolio in the Asia Pacific Asean region. This agreement covers China, the India subcontinent, Australia, New Zealand, and other ASEAN markets. "We are excited to partner with a well-established and reputable company such as Smith+Nephew" said Fiagon Group President & CEO Dr Continue reading →

Posted in Medical Technology | Comments Off on Fiagon partners with Smith+Nephew to distribute its ENT surgical navigation portfolio in the Asia Pacific region – BioSpace

AdvaMed launches platform to help scale the production and distribution of ventilators – Medical Plastics News

Posted: Published on May 6th, 2020

The Advanced Medical Technology Association (AdvaMed) has announced the launch of a new platform, which will attempt to connect ventilator companies with component suppliers to ensure quick scale production and distribution of these devices during the Covid-19 pandemic. The new platform, http://www.VentConnect.org, was developed alongside industry alliances and partners, including Aerospace Industries Association (AIA) which represents more than 300 high-tech manufacturers and suppliers of varying sizes from a range of sectors Continue reading →

Posted in Medical Technology | Comments Off on AdvaMed launches platform to help scale the production and distribution of ventilators – Medical Plastics News

AdvaMed Announces VentConnect Online Platform to Scale the Production and Distribution of Ventilators – Business Wire

Posted: Published on May 6th, 2020

WASHINGTON--(BUSINESS WIRE)--As part of the medical technology industrys multi-front battle to combat the coronavirus (COVID-19) pandemic, today the Advanced Medical Technology Association (AdvaMed) announced the launch of a new platform (www.VentConnect.org) to connect ventilator companies with component suppliers to help quickly scale production and distribution of these vital devices. The new platform was developed pro bono with the Aerospace Industries Association (AIA), Google, and other industry alliances and partners. AIA represents more than 300 high-tech manufacturers and suppliers of all sizes across a range of sectors. Continue reading →

Posted in Medical Technology | Comments Off on AdvaMed Announces VentConnect Online Platform to Scale the Production and Distribution of Ventilators – Business Wire

What is driving the Interventional Fluoroscopy Systems? Market size? Key players are EMD Medical Technologies, GE Healthcare, Lepu Medical Technology,…

Posted: Published on May 6th, 2020

The Latest research study released by MARKETINTELLICA Interventional Fluoroscopy Systems market with 100+ pages of analysis on business strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. The research study provides estimates for Global Interventional Fluoroscopy Systems market forecasted till 2025* Continue reading →

Posted in Medical Technology | Comments Off on What is driving the Interventional Fluoroscopy Systems? Market size? Key players are EMD Medical Technologies, GE Healthcare, Lepu Medical Technology,…

Outlook on the Worldwide Sleep Apnea Therapeutic & Diagnostic Devices Industry to 2024 – Insights & Forecast with Potential Impact of COVID-19…

Posted: Published on May 6th, 2020

May 05, 2020 07:13 ET | Source: Research and Markets Dublin, May 05, 2020 (GLOBE NEWSWIRE) -- The "Global Sleep Apnea Therapeutic & Diagnostic Devices Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering. The factors such as the expansion of medical devices, rising prevalence of obstructive sleep apnea (OSA), growth in the geriatric population, increasing medical technology R&D spending and rise in obesity would drive the growth of the global sleep apnea device market Continue reading →

Posted in Medical Technology | Comments Off on Outlook on the Worldwide Sleep Apnea Therapeutic & Diagnostic Devices Industry to 2024 – Insights & Forecast with Potential Impact of COVID-19…

Page 864«..1020..863864865866..870880..»